Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04844281 · ClinicalTrials.gov registry record · NA
Wear Experience With Daily Toric Contact Lenses Over a Long Day
A NA study of Contact Lens and Astigmatism of Both Eyes, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04844281: Completed NA study of Contact Lens and Astigmatism of Both Eyes, sponsored by Ohio State University.
NCT04844281 is a NA study of Contact Lens and Astigmatism of Both Eyes that has completed, run by Ohio State University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04844281, a NA study of Contact Lens and Astigmatism of Both Eyes, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is evaluating the wear experience of a daily toric contact lens after 10, 12, 14, and 16 hours of lens wear.
Primary Outcome
1 describes poor experience, and 10 describes excellent experience.
Conditions Studied
Interventions
- DEVICE Precision1® Daily Disposable Toric Contact Lens
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-05-11 |
| Est. Completion | 2021-08-24 |
| Phase | NA |
What the finished NCT04844281 record still lists
NCT04844281 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Contact Lens appearing as the primary indexed condition, and to 1 intervention - of which Precision1® Daily Disposable Toric Contact Lens is the first listed.
NCT04844281 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04844281 about?
NCT04844281 is a clinical study titled "Wear Experience With Daily Toric Contact Lenses Over a Long Day". This study is evaluating the wear experience of a daily toric contact lens after 10, 12, 14, and 16 hours of lens wear.
What is the current status of trial NCT04844281?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-05-11. Estimated completion is 2021-08-24.
What conditions does trial NCT04844281 study?
This clinical trial studies the following conditions: Contact Lens, Astigmatism of Both Eyes.
What interventions are being tested in trial NCT04844281?
The interventions under investigation include: Precision1® Daily Disposable Toric Contact Lens (DEVICE).
Who is sponsoring clinical trial NCT04844281?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04844281 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contact Lens
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04844281's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI